Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
KR -  Seoul
CN -  Taipei City
TH -  Bangkok
NZ -  New Zealand

North America

US -  San Francisco
US -  Boston

GLOBAL

English

SOLUTIONS

RESOURCES

ABOUT US

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
KR -  Seoul
CN -  Taipei City
TH -  Bangkok
NZ -  New Zealand

North America

US -  San Francisco
US -  Boston

GLOBAL

English

Australian CRO Novotech announces expanded Asia reach into Hong Kong and Philippines at DIA 2013

Australian CRO Novotech announces expanded Asia reach into Hong Kong and Philippines at DIA 2013

December 19,2014

As a leading regional CRO, Novotech has been actively involved in hundreds of drug development programs in the Asia Pacific over the past 17 years. Novotech is attending DIA 2013 49th Annual Meeting (Booth #734 Map).

CEO Alek Safarian said Hong Kong and the Philippines were significant markets that were in high demand from USA and EU based pharma and biotech sponsors.

Hong Kong has a long history of attracting global clinical trials having participated in over 1000 global clinical trials since 1996.